SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-003205
Filing Date
2019-01-07
Accepted
2019-01-07 08:11:33
Documents
3
Period of Report
2019-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d676111d8k.htm 8-K 15966
2 EX-99.1 d676111dex991.htm EX-99.1 23991
3 GRAPHIC g676111g50e32.jpg GRAPHIC 4238
  Complete submission text file 0001193125-19-003205.txt   47103
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 19512242
SIC: 2834 Pharmaceutical Preparations